Stock listing
NASDAQ:FULC Fulcrum Therapeutics, Inc. Stock
Home listing (NASDAQ) of Fulcrum Therapeutics, Inc.
Follow Fulcrum Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:FULC
$3.65 USD -0.06 (-1.6%)
Close on Nov 2, 2026
- Day range
- $3.64 – $3.73 USDNov 2, 2026
- Volume
- 1.21M sharesNov 2, 2026
- Market cap
- $278.8M USDAt the close on Nov 2, 2026 · price × 76.38M shares outstanding
- 52-week range
- $2.83 – $15.74 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $5.77M USDMedian day 1.32M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:FULC · Home | $3.65 USD | -0.06 (-1.6%) | 1,213,772 | $3.72 | $3.725 | $3.64 | $3.71 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:FULC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.65 | -0.06 | -1.6% | $3.72 | $3.725 | $3.64 | 1,213,772 | |
| $3.71 | -0.06 | -1.6% | $3.74 | $3.755 | $3.68 | 933,217 | |
| $3.77 | +0.02 | +0.5% | $3.77 | $3.795 | $3.73 | 1,620,602 | |
| $3.75 | +0.05 | +1.4% | $3.69 | $3.77 | $3.67 | 1,998,393 | |
| $3.70 | +0.06 | +1.6% | $3.66 | $3.735 | $3.63 | 1,903,728 | |
| $3.64 | -0.04 | -1.1% | $3.69 | $3.69 | $3.63 | 773,326 | |
| $3.68 | 0.00 | 0.0% | $3.68 | $3.69 | $3.64 | 1,067,349 | |
| $3.68 | -0.02 | -0.5% | $3.71 | $3.735 | $3.66 | 2,309,020 | |
| $3.70 | -0.02 | -0.5% | $3.72 | $3.745 | $3.70 | 923,781 | |
| $3.72 | +0.02 | +0.5% | $3.71 | $3.75 | $3.695 | 757,122 | |
| $3.70 | +0.05 | +1.4% | $3.67 | $3.72 | $3.66 | 1,194,922 | |
| $3.65 | -0.02 | -0.5% | $3.68 | $3.685 | $3.64 | 1,385,300 | |
| $3.67 | 0.00 | 0.0% | $3.71 | $3.725 | $3.66 | 1,225,800 | |
| $3.67 | -0.01 | -0.3% | $3.67 | $3.715 | $3.65 | 1,661,600 | |
| $3.68 | -0.07 | -1.9% | $3.75 | $3.75 | $3.675 | 1,457,100 | |
| $3.75 | -0.02 | -0.5% | $3.77 | $3.77 | $3.73 | 1,614,100 | |
| $3.77 | +0.02 | +0.5% | $3.75 | $3.785 | $3.72 | 1,798,900 | |
| $3.75 | +0.08 | +2.2% | $3.66 | $3.775 | $3.66 | 2,631,700 | |
| $3.67 | -0.02 | -0.5% | $3.70 | $3.72 | $3.67 | 1,041,500 | |
| $3.69 | -0.02 | -0.5% | $3.72 | $3.725 | $3.68 | 757,000 | |
| $3.71 | +0.02 | +0.5% | $3.70 | $3.73 | $3.68 | 1,062,200 | |
| $3.69 | +0.01 | +0.3% | $3.72 | $3.76 | $3.65 | 1,540,400 | |
| $3.68 | -0.02 | -0.5% | $3.70 | $3.72 | $3.67 | 1,227,500 | |
| $3.70 | 0.00 | 0.0% | $3.73 | $3.73 | $3.665 | 1,918,400 | |
| $3.70 | -0.02 | -0.5% | $3.73 | $3.785 | $3.685 | 1,842,700 | |
| $3.72 | -0.02 | -0.5% | $3.75 | $3.76 | $3.71 | 901,200 | |
| $3.74 | -0.045 | -1.2% | $3.80 | $3.81 | $3.71 | 2,493,000 | |
| $3.785 | -0.025 | -0.7% | $3.82 | $3.82 | $3.745 | 1,948,300 | |
| $3.81 | -0.03 | -0.8% | $3.86 | $3.86 | $3.795 | 1,194,400 | |
| $3.84 | +0.04 | +1.1% | $3.80 | $3.845 | $3.79 | 978,900 | |
| $3.80 | +0.04 | +1.1% | $3.80 | $3.80 | $3.75 | 731,400 | |
| $3.76 | -0.01 | -0.3% | $3.77 | $3.805 | $3.755 | 3,655,700 | |
| $3.77 | -0.02 | -0.5% | $3.81 | $3.82 | $3.755 | 888,100 | |
| $3.79 | +0.01 | +0.3% | $3.80 | $3.815 | $3.77 | 1,125,200 | |
| $3.78 | -0.01 | -0.3% | $3.80 | $3.80 | $3.75 | 1,327,000 | |
| $3.79 | -0.01 | -0.3% | $3.82 | $3.82 | $3.775 | 706,500 | |
| $3.80 | 0.00 | 0.0% | $3.85 | $3.85 | $3.78 | 814,800 | |
| $3.80 | -0.04 | -1.0% | $3.82 | $3.835 | $3.79 | 1,328,000 | |
| $3.84 | +0.02 | +0.5% | $3.82 | $3.85 | $3.78 | 1,385,000 | |
| $3.82 | -0.03 | -0.8% | $3.80 | $3.85 | $3.795 | 1,109,600 | |
| $3.85 | +0.01 | +0.3% | $3.81 | $3.855 | $3.80 | 1,004,700 | |
| $3.84 | -0.01 | -0.3% | $3.87 | $3.89 | $3.82 | 1,435,500 | |
| $3.85 | -0.02 | -0.5% | $3.88 | $3.90 | $3.825 | 1,633,500 | |
| $3.87 | -0.02 | -0.5% | $3.85 | $3.88 | $3.82 | 1,681,900 | |
| $3.89 | +0.04 | +1.0% | $3.83 | $3.915 | $3.796 | 1,798,200 | |
| $3.85 | 0.00 | 0.0% | $3.82 | $3.87 | $3.78 | 1,890,600 | |
| $3.85 | -0.01 | -0.3% | $3.86 | $3.89 | $3.825 | 785,000 | |
| $3.86 | 0.00 | 0.0% | $3.86 | $3.88 | $3.82 | 854,900 | |
| $3.86 | +0.02 | +0.5% | $3.87 | $3.89 | $3.835 | 1,320,100 | |
| $3.84 | +0.01 | +0.3% | $3.835 | $3.86 | $3.78 | 856,200 | |
| $3.83 | -0.02 | -0.5% | $3.85 | $3.90 | $3.78 | 1,512,600 | |
| $3.85 | -0.06 | -1.5% | $3.88 | $3.907 | $3.81 | 1,197,600 | |
| $3.91 | +0.04 | +1.0% | $3.90 | $3.94 | $3.855 | 2,179,200 | |
| $3.87 | +0.03 | +0.8% | $3.85 | $3.90 | $3.745 | 2,751,100 | |
| $3.84 | +0.10 | +2.7% | $3.81 | $3.90 | $3.751 | 8,440,000 | |
| $3.74 | +0.03 | +0.8% | $3.70 | $3.755 | $3.65 | 980,400 | |
| $3.71 | -0.01 | -0.3% | $3.75 | $3.76 | $3.64 | 1,357,500 | |
| $3.72 | +0.03 | +0.8% | $3.70 | $3.74 | $3.615 | 901,400 | |
| $3.69 | -0.06 | -1.6% | $3.77 | $3.775 | $3.655 | 804,119 | |
| $3.75 | -0.14 | -3.6% | $3.85 | $3.87 | $3.74 | 1,122,442 | |
| $3.89 | +0.12 | +3.2% | $3.83 | $3.91 | $3.77 | 1,460,100 | |
| $3.77 | 0.00 | 0.0% | $3.76 | $3.815 | $3.685 | 1,041,500 | |
| $3.77 | -0.03 | -0.8% | $3.80 | $3.82 | $3.72 | 1,254,200 | |
| $3.80 | +0.09 | +2.4% | $3.73 | $3.835 | $3.695 | 2,349,300 | |
| $3.71 | +0.13 | +3.6% | $3.63 | $3.725 | $3.544 | 2,262,400 |
- Ticker
- NASDAQ:FULC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Aug 17, 2026
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
Latest earnings call · Apr 27, 2026
Fulcrum Therapeutics (NASDAQ:FULC) Q1 2026 Earnings Call
Replay and transcript
Latest deck · Aug 17, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 26 slides
Calls
Replays
Fulcrum Therapeutics (NASDAQ:FULC) Q1 2026 Earnings Call
Mon, Apr 27, 2026 · 8:00 AM ET
Watch TranscriptFulcrum Therapeutics (NASDAQ:FULC) Q3 2025 Earnings Call
Wed, Oct 29, 2025 · 8:00 AM ET
Watch TranscriptFulcrum Therapeutics (NASDAQ:FULC) Q1 2025 Earnings Call
Thu, May 01, 2025 · 6:00 PM ET
Watch Transcript
Latest news
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
Aug 17, 2026
Closed $3.84 (+2.7%) on Aug 17, 2026
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
Jun 1, 2026
Closed $3.14 (-51.1%) on Jun 2, 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
Apr 27, 2026
Closed $7.72 (-1.5%) on Apr 27, 2026
Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors
Apr 27, 2026
Closed $7.72 (-1.5%) on Apr 27, 2026
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8: 00 a.m. ET
Apr 20, 2026
Closed $7.94 (-4.2%) on Apr 20, 2026
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
Mar 19, 2026
Closed $7.04 (+1.7%) on Mar 19, 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Feb 24, 2026
Closed $8.58 (-21.2%) on Feb 24, 2026
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Feb 24, 2026
Closed $8.58 (-21.2%) on Feb 24, 2026
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 9, 2026
Closed $9.51 (-3.5%) on Jan 12, 2026
Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Jan 7, 2026
Closed $9.98 (-0.1%) on Jan 7, 2026
Financings
Private placement of concurrent private placement (Slate shares)
Aug 17, 2026
Announced: US$245M
Buyers: Frazier Life Sciences; Forbion; RA Capital Management; Deep Track Capital; Foresite Capital; OrbiMed; RTW Investments; Mingxin Capital
Use of proceeds: Fund operations into 2029 and advance SLTE-1009 through Phase 1 and Phase 2 studies and the rest of Slate's pipeline
Decks
Merger or Acquisition (August 2026)
Merger or acquisition · 26 slides · Aug 17, 2026
Investor Presentation (January 2026)
Investor deck · 28 slides · Jan 12, 2026
Technical Presentation (December 2025)
Technical · 31 slides · Dec 8, 2025
Investor Presentation (August 2025)
Investor deck · 30 slides · Aug 28, 2025
Fulcrum Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 166 in all · newest Aug 17, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Apr 27, 2026
- Decks
- 11 decks · latest Aug 17, 2026
Where Fulcrum Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FULC · Home listing · This page | NASDAQ | United States | USD |
| BOATS:FULC | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Fulcrum Therapeutics, Inc.